Literature DB >> 29630105

MiR-1182 inhibited metastasis and proliferation of ovarian cancer by targeting hTERT.

X-S Hou1, C-Q Han, W Zhang.   

Abstract

OBJECTIVE: To investigate the potential effect of miR-1182 on the development of ovarian cancer and the relevant mechanism. PATIENTS AND METHODS: The expression levels of miR-1182 were detected in ovarian cancer tissues and cells (SKOV3) comparing with corresponding adjacent normal tissues and normal ovarian cell (IOSE80). Luciferase assay was performed to evaluate the interaction between miR-1182 and hTERT. The effects of the miR-1182/hTERT axis on SKOV3 cells were determined by subsequent experiments including cell proliferation, expression level of hTERT, the invasion and metastasis detection.
RESULTS: miR-1182 was found repressed in ovarian cancer tissues and we got the same results at the cellular level. In order to research potential target of miR-1182, we checked it in three publicly available algorithms, TargetScan, miRDB and microRNA. We found that hTERT is a direct target of miR-1182, and luciferase assays confirmed our hypothesis. The subsequent experiments showed that decreased expression of hTERT resulting from the up-regulation of miR-1182 could decelerate cell proliferation, invasion, and metastasis in ovarian cancer cells.
CONCLUSIONS: Our research discovers the suppressor function of miR-1182 in ovarian cancer by targeting hTERT, revealing that miR-1182/hTERT axis may be a potential therapeutic target for the treatment of ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29630105     DOI: 10.26355/eurrev_201803_14569

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  12 in total

1.  In Silico Analysis of Micro-RNA Sequencing Data.

Authors:  Ernesto Aparicio-Puerta; Bastian Fromm; Michael Hackenberg; Marc K Halushka
Journal:  Methods Mol Biol       Date:  2021

2.  Circ_0061395 functions as an oncogenic gene in hepatocellular carcinoma by acting as a miR-1182 sponge.

Authors:  Wen Wu; Zhenhua Zhou; Chao Chen; Ming Chen
Journal:  Cell Cycle       Date:  2022-07-01       Impact factor: 5.173

3.  Circ_0002476 regulates cell growth, invasion, and mtDNA damage in non-small cell lung cancer by targeting miR-1182/TFAM axis.

Authors:  Weijie Wang; Haiting Sun; Xuan Ma; Ting Zhu; Haina Zhang
Journal:  Thorac Cancer       Date:  2022-09-03       Impact factor: 3.223

Review 4.  Mechanism of Human Telomerase Reverse Transcriptase (hTERT) Regulation and Clinical Impacts in Leukemia.

Authors:  Mot Yee Yik; Adam Azlan; Yaashini Rajasegaran; Aliaa Rosli; Narazah Mohd Yusoff; Emmanuel Jairaj Moses
Journal:  Genes (Basel)       Date:  2021-07-30       Impact factor: 4.096

5.  Exosomal Circ-XIAP Promotes Docetaxel Resistance in Prostate Cancer by Regulating miR-1182/TPD52 Axis.

Authors:  Hui Zhang; Minghui Li; Jing Zhang; Yanbing Shen; Qi Gui
Journal:  Drug Des Devel Ther       Date:  2021-05-03       Impact factor: 4.162

6.  MirGeneDB 2.0: the metazoan microRNA complement.

Authors:  Bastian Fromm; Diana Domanska; Eirik Høye; Vladimir Ovchinnikov; Wenjing Kang; Ernesto Aparicio-Puerta; Morten Johansen; Kjersti Flatmark; Anthony Mathelier; Eivind Hovig; Michael Hackenberg; Marc R Friedländer; Kevin J Peterson
Journal:  Nucleic Acids Res       Date:  2020-01-08       Impact factor: 16.971

7.  LINC01207 promotes prostate cancer progression by sponging miR-1182 to upregulate AKT3.

Authors:  Daming Qin; Cheng Ni; Biyong Tan; Shengfei Huang; Bingqing Deng; Zhihua Huang
Journal:  Oncol Lett       Date:  2021-12-21       Impact factor: 2.967

8.  Circ_MUC16 attenuates the effects of Propofol to promote the aggressive behaviors of ovarian cancer by mediating the miR-1182/S100B signaling pathway.

Authors:  Hao Yang; Yunrui Guo; Yecai Zhang; Decai Wang; Guoyun Zhang; Jiali Hou; Jianming Yang
Journal:  BMC Anesthesiol       Date:  2021-11-27       Impact factor: 2.217

9.  CircWHSC1 promotes ovarian cancer progression by regulating MUC1 and hTERT through sponging miR-145 and miR-1182.

Authors:  Zhi-Hong Zong; Yu-Ping Du; Xue Guan; Shuo Chen; Yang Zhao
Journal:  J Exp Clin Cancer Res       Date:  2019-10-30

Review 10.  Small Non-Coding-RNA in Gynecological Malignancies.

Authors:  Shailendra Kumar Dhar Dwivedi; Geeta Rao; Anindya Dey; Priyabrata Mukherjee; Jonathan D Wren; Resham Bhattacharya
Journal:  Cancers (Basel)       Date:  2021-03-03       Impact factor: 6.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.